Pedro Rozas-Moreno - Concepedia

Author

Pedro Rozas-Moreno

Instituto de Investigación Biosanitaria de Granada ORCID

Also Known As

P. Rozas-Moreno, Pedro Rozas-Moreno, Rozas-Moreno, P

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Instituto de Investigación Biosanitaria de Granada Hospital General Universitario de Ciudad Real Hospital Rafael Méndez Universidad de Granada Instituto de Salud Carlos III

About

Pedro Rozas-Moreno is an author at Instituto de Investigación Biosanitaria de Granada specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	427
2	Health Sciences	5	5	241
3	Public Health	2	2	110
4	Biochemistry	2	2	74
5	Natural Sciences	1	1	21

Pedro Rozas-Moreno

Publications

958

Citations

H-Index

Page 1

	Year	Citations
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus Antonia García‐Martin, Pedro Rozas-Moreno, Rebeca Reyes‐García, The Journal of Clinical Endocrinology & Metabolism	2011	310
Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels Sonia Morales, Beatriz García-Fontana, Antonia García‐Martin, Diabetes Care	2013	133
Serum levels of bone resorption markers are decreased in patients with type 2 diabetes Rebeca Reyes‐García, Pedro Rozas-Moreno, Gema López-Gallardo, Acta Diabetologica ObesityMetabolic SyndromeBone DiseaseBone HealthDiabetes	2011	83
Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study Beatriz García-Fontana, Sonia Morales, Caridad Díaz, Talanta Metabolic SyndromeCardiovascular DiseaseGlobal HealthDiabetesType 2	2015	60
Role of serum FSH measurement on bone resorption in postmenopausal women Antonia García‐Martin, Rebeca Reyes‐García, José Miguel García-Castro, Endocrine Bone HealthBone ResorptionGynecologySerum Fsh MeasurementMenopause	2011	55
Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state? Beatriz García-Fontana, Rebeca Reyes‐García, Sonia Morales, Endocrine Metabolic SyndromeSystems BiologySignal TransductionCompensatory MechanismBiochemistry	2015	53
Circulating levels of sclerostin are associated with cardiovascular mortality Cristina Novo‐Rodríguez, Beatriz García-Fontana, Juan De Dios Luna-Del Castillo, PLoS ONE Vascular DiseaseCardiometabolic RiskSerum SclerostinCardiovascular DiseasesMetabolic Syndrome	2018	50
Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes Rebeca Reyes‐García, Pedro Rozas-Moreno, José Juan Jiménez‐Moleón, Diabetes & Metabolism Metabolic SyndromeCardiovascular DiseasePhysiologyDiabetesType 2	2011	49
Osteocalcin as a marker of metabolic risk in healthy postmenopausal women Antonia García‐Martin, María Cortés-Berdonces, Inés Luque-Fernández, Menopause The Journal of The North American Menopause Society NutritionCardiometabolic RiskGynecologyCaloric RestrictionOsteoporosis	2010	45
Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus Antonia García‐Martin, Rebeca Reyes‐García, Beatriz García-Fontana, PLoS ONE	2014	44

Page 1